SynthesisObesity surgery2026
Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Obese Kidney Transplant Candidates: A Systematic Review, Meta-Analysis, and Development of a Transplant-Specific Decision Framework.
Synthesis in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity remains a major barrier to kidney transplantation and is associated with inferior transplant outcomes. We conducted a PRISMA 2020-compliant systematic review and meta-analysis comparing sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in kidney transplant candidates and recipients. PubMed/MEDLINE, Embase, Scopus, and Cochrane CENTRAL were searched through January 2026. Eleven observational studies involving 2,553 patients (1,461 SG; 1,092 RYGB) were included. SG was associated with lower mortality (RR 0.46, 95% CI 0.32-0.66) and graft loss (RR 0.39, 95% CI 0.21-0.73) than RYGB, while access to transplantation was similar between procedures. SG also demonstrated fewer nutritional complications and greater pharmacokinetic stability. Current evidence suggests that SG may be the preferred bariatric procedure among kidney transplant recipients, although prospective comparative studies are needed.
Indexed as
Identifiers
42440048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.